HDAC9 and central nervous system cancer: It has been demonstrated, that HDAC inhibitors sensitize gliomas and other types of cancer to chemotherapeutic agents and radiation, including: trichostatin (TSA), SAHA (vorinostat), valproic acid (VPA), LBH589 (panobinostat), MS275 (entinostat), PXD101 (belinostat)3–19.